Seyed Sina Naghibi Irvani

Dados Biográficos

ID1861815
NOMESeyed Sina Naghibi Irvani
PRENOMESSeyed Sina Naghibi
SOBRENOMEIrvani
ASSINATURAIRVANI S S N
AFILIAÇÕESShahid Beheshti University of Medical Sciences
ORCID0000-0002-4566-7402
VERIFICADOSim
TOTAL DE OBRAS28
TOTAL DE CITAÇÕES1
TOTAL COMO AUTOR28
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2018
ANO MAIS RECENTE DE PUBLICAÇÃO2022
ÍNDICE H1

  • Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050

    Open AccessEmma Nichols, Jaimie D Steinmetz et al.ARTICLEThe Lancet Public Health2022

    BACKGROUND: Given the projected trends in population ageing and population growth, the number of people with dementia is expected to increase. In addition, strong evidence has emerged supporting the importance of potentially modifiable risk factors for dementia. Characterising the distribution and magnitude of anticipated growth is crucial for public health planning and resource prioritisation. This study aimed to improve on previous forecasts of…

  • Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to Vision 2020

    Open AccessJaimie D Steinmetz, Rupert R A Bourne et al.ARTICLEThe Lancet Global Health2021

    BACKGROUND: Many causes of vision impairment can be prevented or treated. With an ageing global population, the demands for eye health services are increasing. We estimated the prevalence and relative contribution of avoidable causes of blindness and vision impairment globally from 1990 to 2020. We aimed to compare the results with the World Health Assembly Global Action Plan (WHA GAP) target of a 25% global reduction from 2010 to 2019 in avoidab…

  • Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019

    Open AccessMarissa B Reitsma, Parkes J Kendrick et al.ARTICLEThe Lancet2021

    BACKGROUND: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. METHODS: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global B…

  • Trends in prevalence of blindness and distance and near vision impairment over 30 years

    Open AccessRupert Bourne, Jaimie D Steinmetz et al.ARTICLEThe Lancet Global Health2021

    BACKGROUND: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of global vision impairment in 2020 and temporal change is needed. We aimed to extensively update estimates of global vision loss burden, presenting estimates for 2020, temporal change over three decades between 1990-2020, and forecasts for 2050. METHODS: We did a systematic review and meta-analysis of population-based surveys of eye disease from Janua…

  • Hearing loss prevalence and years lived with disability, 1990–2019

    Open AccessLydia M Haile, Kaloyan Kamenov et al.ARTICLEThe Lancet2021

    BACKGROUND: Hearing loss affects access to spoken language, which can affect cognition and development, and can negatively affect social wellbeing. We present updated estimates from the Global Burden of Disease (GBD) study on the prevalence of hearing loss in 2019, as well as the condition's associated disability. METHODS: We did systematic reviews of population-representative surveys on hearing loss prevalence from 1990 to 2019. We fitted nested…

  • Global, regional, and national burden of stroke and its risk factors, 1990–2019

    Open AccessValery L Feigin, Benjamin A Stark et al.ARTICLEThe Lancet Neurology2021

    BACKGROUND: Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national leve…

  • Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000-2018

    Open AccessNatalia V Bhattacharjee, Lauren E Schaeffer et al.ARTICLENature Human Behaviour2021Citada por: 1Referências: 32

    Exclusive breastfeeding (EBF)-giving infants only breast-milk for the first 6 months of life-is a component of optimal breastfeeding practices effective in preventing child morbidity and mortality. EBF practices are known to vary by population and comparable subnational estimates of prevalence and progress across low- and middle-income countries (LMICs) are required for planning policy and interventions. Here we present a geospatial analysis of E…

  • Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017

    Open AccessJoan B Soriano, Parkes J Kendrick et al.ARTICLEThe Lancet Respiratory Medicine2020

    BACKGROUND: Previous attempts to characterise the burden of chronic respiratory diseases have focused only on specific disease conditions, such as chronic obstructive pulmonary disease (COPD) or asthma. In this study, we aimed to characterise the burden of chronic respiratory diseases globally, providing a comprehensive and up-to-date analysis on geographical and time trends from 1990 to 2017. METHODS: Using data from the Global Burden of Disease…

  • Five insights from the Global Burden of Disease Study 2019

    Open AccessChristopher J L Murray, Cristiana Abbafati et al.ARTICLEThe Lancet2020

  • Global, regional, and national burden of chronic kidney disease, 1990–2017

    Open AccessBoris Bikbov, Caroline Purcell et al.ARTICLEThe Lancet2020

    BACKGROUND: Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries. We estimated the global, regional, and national burden of CKD, as well as the burden of cardiovascular disease and gout attributable to impaired kidney function, for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. We use…

  • Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019

    Open AccessR Lozano, Nancy Fullman et al.ARTICLEThe Lancet2020

    BACKGROUND: Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system le…

  • Global burden of 87 risk factors in 204 countries and territories, 1990–2019

    Open AccessChristopher J L Murray, Aleksandr Y Aravkin et al.ARTICLEThe Lancet2020

    BACKGROUND: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attribu…

  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019

    Open AccessTheo Vos, Stephen S Lim et al.ARTICLEThe Lancet2020

    BACKGROUND: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive…

  • Global, regional, and national burden of neurological disorders, 1990–2016

    Open AccessValery L Feigin, Emma Nichols et al.ARTICLEThe Lancet Neurology2019

    BACKGROUND: Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 is to provide the most comprehensive and up-to-date estimates of the global, regional, and national burden from neurological disorders. METHODS: We estimated prevalence, incidence, deaths, and disability-adjusted life-years (DALYs;…

  • Past, present, and future of global health financing

    Open AccessAlenda Y Chang, Angela Y Chang et al.ARTICLEThe Lancet2019

    BACKGROUND: Comprehensive and comparable estimates of health spending in each country are a key input for health policy and planning, and are necessary to support the achievement of national and international health goals. Previous studies have tracked past and projected future health spending until 2040 and shown that, with economic development, countries tend to spend more on health per capita, with a decreasing share of spending from developme…

  • Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

    Open AccessChristina Fitzmaurice, Global Burden of Disease Cancer Collaboration et al.ARTICLEJAMA Oncology2019

    Importance Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation and also highlighted the slow progress in meeting the 2011 Political Declaration on the Prevention and Control of Noncommunicable Diseases and the third Sustainable Development Goal. Lack of situational analyses, priority setting, and budgeting hav…

  • Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories

    Open AccessTahvi D Frank, Tahvi Frank et al.ARTICLEThe Lancet HIV2019

    BACKGROUND: Understanding the patterns of HIV/AIDS epidemics is crucial to tracking and monitoring the progress of prevention and control efforts in countries. We provide a comprehensive assessment of the levels and trends of HIV/AIDS incidence, prevalence, mortality, and coverage of antiretroviral therapy (ART) for 1980-2017 and forecast these estimates to 2030 for 195 countries and territories. METHODS: We determined a modelling strategy for ea…

  • Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016

    Open AccessEmma Nichols, Cassandra Szoeke et al.ARTICLEThe Lancet Neurology2019

    BACKGROUND: The number of individuals living with dementia is increasing, negatively affecting families, communities, and health-care systems around the world. A successful response to these challenges requires an accurate understanding of the dementia disease burden. We aimed to present the first detailed analysis of the global prevalence, mortality, and overall burden of dementia as captured by the Global Burden of Diseases, Injuries, and Risk …

  • Global, regional, and national burden of stroke, 1990–2016

    Open AccessCatherine Owens Johnson, Minh Nguyen et al.ARTICLEThe Lancet Neurology2019

    BACKGROUND: Stroke is a leading cause of mortality and disability worldwide and the economic costs of treatment and post-stroke care are substantial. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic, comparable method of quantifying health loss by disease, age, sex, year, and location to provide information to health systems and policy makers on more than 300 causes of disease and injury, including strok…

  • Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran

    Open AccessAli Eslami, Seyed Sina Naghibi Irvani et al.ARTICLEBMC Public Health2019

    Controlling three modifiable risk factors including diabetes, hypertension and smoking might potentially reduce mortality events by over 40%, and among these, prevention of diabetes should be prioritized to decrease burden of events. We didn't confirm a negative impact of overweight and obesity status on premature mortality events

  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017

    Open AccessDaniel Dicker, Grant Nguyen et al.ARTICLEThe Lancet2018

    BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent wit…

  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017

    Open AccessGregory A Roth, D Abate et al.ARTICLEThe Lancet2018

    BACKGROUND: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD …

  • Alcohol use and burden for 195 countries and territories, 1990–2016

    Open AccessMax Griswold, Max G Griswold et al.ARTICLEThe Lancet2018

    BACKGROUND: Alcohol use is a leading risk factor for death and disability, but its overall association with health remains complex given the possible protective effects of moderate alcohol consumption on some conditions. With our comprehensive approach to health accounting within the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we generated improved estimates of alcohol use and alcohol-attributable deaths and disability-adjus…

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017

    Open AccessJeffrey D Stanaway, Ashkan Afshin et al.ARTICLEThe Lancet2018

    BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associatio…

  • Global, regional, and national disability-adjusted life-years (Dalys) for 359 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2017

    Open AccessHmwe Hmwe Kyu, D Abate et al.ARTICLEThe Lancet2018

    BACKGROUND: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure o…